Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVANOS MEDICAL, INC.AVNS · Entity 28189 | Former Chief Executive Officer | March 06, 2025 | March 10, 2025 |
| AVITA Medical, Inc.RCEL · Entity 5905 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVANOS MEDICAL, INC.
Report date March 06, 2025 · Filed March 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 402,776 |
Ending reported balance
After 2025-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-06 · Tax withholding · Disposed 11,827 · Balance 423,025 F1: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 28,561 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock. Row 2 · 2025-03-06 · Tax withholding · Disposed 20,249 · Balance 402,776 F2: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 45,258 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 28,561 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
F2: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 45,258 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
AVITA Medical, Inc.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 107,961 |
Reported balance
After 2026-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-09 · Purchase · Acquired 5,200 · Balance 107,961 F1: Includes unvested RSUs |
Filing footnotes · ownership attribution and instrument terms
F1: Includes unvested RSUs
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 9, 2026 20:58 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.18 | $20,900.00 |
DisclosureSEC source: 0001193125-26-263968 · ownership.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,761 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 09, 2026 Filed Jun 9, 2026 20:58 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.20 | $21,000.00 |
DisclosureSEC source: 0001193125-26-263968 · ownership.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,761 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 01:17 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,200 | $4.00 | $20,800.00 |
DisclosureSEC source: 0001193125-26-266397 · ownership.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,961 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:00 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.09 | $20,449.50 |
DisclosureSEC source: 0001709989-26-000011 · ownership.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,761 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:00 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.10 | $20,499.50 |
DisclosureSEC source: 0001709989-26-000011 · ownership.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,761 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.21 | $21,035.50 |
DisclosureSEC source: 0001709989-26-000006 · ownership.xml · nonDerivative · entry 4 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.18 | $20,901.00 |
DisclosureSEC source: 0001709989-26-000006 · ownership.xml · nonDerivative · entry 3 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.26 | $21,300.00 |
DisclosureSEC source: 0001709989-26-000006 · ownership.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:30 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | PurchaseCommon Stock | 5,000 | $4.34 | $21,700.00 |
DisclosureSEC source: 0001709989-26-000006 · ownership.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| January 20, 2026 Filed Jun 4, 2026 23:10 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 16,133 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001709989-26-000008 · ownership.xml · derivative · entry 4 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,133 Underlying: Common Stock · 16,133 shares Expires 2036-01-20 F6 · derivative.exercise_price: On January 5, 2026, the Board of Directors approved a grant of 16,133 options to acquire 16,133 shares of Common Stock to each of its non-executive directors, with a grant date of January 20, 2026 (the "Grant Date") and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on the Grant Date of $3.77. This option grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. Read SEC document |
| January 20, 2026 Filed Jun 4, 2026 23:10 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 22,214 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001709989-26-000008 · ownership.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,761 F3 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date of January 20, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. F2 · balance_after: Includes unvested RSUs Read SEC document |
| January 05, 2026 Filed Jun 4, 2026 23:10 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 29,446 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0001709989-26-000008 · ownership.xml · derivative · entry 3 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,446 Underlying: Common Stock · 29,446 shares Expires 2036-01-05 F4 · derivative.exercise_price: On January 5, 2026, the Board of Directors approved a grant of 29,446 options to acquire 29,446 shares of Common Stock of the Company to Mr. Woody as a new non-executive director, with an effective grant date of January 5, 2026 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 5, 2026 of $3.47. The grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. F5 · derivative.exercise_date: These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date. Read SEC document |
| January 05, 2026 Filed Jun 4, 2026 23:10 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 40,547 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001709989-26-000008 · ownership.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,547 F1 · price: Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the date 12 months following the grant date of January 5, 2026. This grant of RSUs was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026. F2 · balance_after: Includes unvested RSUs Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 15:47 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 20,249 | $15.30 | $309,809.70 |
DisclosureSEC source: 0001606498-25-000040 · wk-form4_1741621667.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Former Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,776 F2 · shares: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 45,258 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 15:47 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 11,827 | $15.30 | $180,953.10 |
DisclosureSEC source: 0001606498-25-000040 · wk-form4_1741621667.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Former Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,025 F1 · shares: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 28,561 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2025. Each TRSU is the economic equivalent of one share of Common Stock. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:25 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 8,184 | $15.13 | $123,823.92 |
DisclosureSEC source: 0001606498-25-000033 · wk-form4_1741289102.xml · nonDerivative · entry 3 Woody Joseph Fralin · CIK 0001709989 · Former Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,852 F4 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 27,518 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:25 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 10,167 | $15.13 | $153,826.71 |
DisclosureSEC source: 0001606498-25-000033 · wk-form4_1741289102.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Former Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,036 F3 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 32,158 PRSUs which vested on March 4, 2025. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:25 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Exercise / conversionCommon Stock | 32,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-25-000033 · wk-form4_1741289102.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Former Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock. F2 · balance_after: Total beneficially owned includes 1,000 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 20:09 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 26,670 | $19.09 | $509,130.30 |
DisclosureSEC source: 0001606498-24-000049 · wk-form4_1710878947.xml · nonDerivative · entry 3 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,045 F3 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 59,477 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 20:09 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 7,095 | $19.09 | $135,443.55 |
DisclosureSEC source: 0001606498-24-000049 · wk-form4_1710878947.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,715 F2 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 15,821 PRSUs which vested on March 18, 2024. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 20:09 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Exercise / conversionCommon Stock | 15,821 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-24-000049 · wk-form4_1710878947.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:59 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 8,868 | $19.00 | $168,492.00 |
DisclosureSEC source: 0001606498-24-000036 · wk-form4_1709848758.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,989 F3 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6, 2025 and the remaining 1/3 will vest on March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:59 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 137,147 | $19.14 | $2,624,993.58 |
DisclosureSEC source: 0001606498-24-000036 · wk-form4_1709848758.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,857 F1 · shares: Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027. F2 · balance_after: Total beneficially owned includes 922 shares acquired on June 30, 2023 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:07 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 8,431 | $18.76 | $158,165.56 |
DisclosureSEC source: 0001606498-24-000024 · wk-form4_1709759251.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,788 F1 · kind: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units (TRSUs) awarded to the Reporting Person on March 4, 2022, of which 1/3 vested on March 4, 2023, 1/3 vested on March 4, 2024 and the remaining 1/3 will vest on March 4, 2025. Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:23 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 57,256 | $23.97 | $1,372,426.32 |
DisclosureSEC source: 0001606498-23-000044 · wf-form4_168366740647246.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,219 F1 · shares: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on May 7, 2020 with a 3-year cliff vesting period. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:40 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 8,314 | $29.62 | $246,260.68 |
DisclosureSEC source: 0001606498-23-000024 · wf-form4_167822522508865.xml · nonDerivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,475 F3 · shares: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:40 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 86,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-23-000024 · wf-form4_167822522508865.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,789 F1 · shares: Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026. F2 · balance_after: Total beneficially owned includes 704 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:26 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 80,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-22-000031 · wf-form4_164675679540667.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,538 F1 · shares: Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025. F2 · balance_after: Total beneficially owned includes 556 shares acquired on June 30, 2021 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 22:32 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 56,147 | $47.29 | $2,655,191.63 |
DisclosureSEC source: 0001606036-21-000007 · primary_doc.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,229 F2 · shares: As reported on the original Form 4 on 3/19/2021, this represents an annual grant of time-vested restricted stock units awarded to Reporting Person on 3/17/2021, with a 3 year cliff vesting period. F1 · price: This Form 4/A is being filed to correct the original Form 4 filed on 3/19/2021. That Form 4 reported the stock price as $47.49, whereas the correct stock price for that grant was $47.29. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:24 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 56,147 | $47.49 | $2,666,421.03 |
DisclosureSEC source: 0001606036-21-000001 · primary_doc.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,229 F1 · shares: Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 3/17/2021, with a 3 year cliff vesting period. Read SEC document |
| March 17, 2021 Filed Sep 10, 2021 20:08 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 59,477 | $47.29 | $2,812,667.33 |
DisclosureSEC source: 0001606498-21-000049 · wf-form4a_163130451930468.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,049 F1 · shares: This Form 4/A is being filed to correct the original number of shares issued to the Reporting Person on 3/17/2021. The original filing reported 56,147 shares issued, whereas the correct number of shares issued were 59,477. This represents an annual grant of time-vested restricted stock units awarded to the Reporting Person on 3/17/2021, with a 3 year cliff vesting period. F2 · balance_after: Total beneficially owned shares include 755 shares acquired on 12/31/2019 and 735 shares on 6/30/2020 under the Issuer's Employee Stock Purchase. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 13:40 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 2,513 | $28.66 | $72,022.58 |
DisclosureSEC source: 0001606498-20-000040 · wf-form4_159352442765804.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,082 F1 · shares: Represents shares withheld for taxes from vesting of time-based restricted stock units granted on 06/26/2017. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:08 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock · Derivative | 135,183 | $30.67 Strike: $30.67 | $4,146,062.61 |
DisclosureSEC source: 0001606498-20-000031 · wf-form4_158923491597575.xml · derivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,183 Underlying: Common Stock · 135,183 shares Expires 2030-05-07 F2 · shares: Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. F3 · derivative.underlying_shares: The award will vest 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:08 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 129,850 | $30.67 | $3,982,499.50 |
DisclosureSEC source: 0001606498-20-000031 · wf-form4_158923491597575.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,595 F1 · shares: Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 5/7/2020, with a 3 year cliff vesting period. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 13:03 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 2,811 | $42.56 | $119,636.16 |
DisclosureSEC source: 0001606036-19-000001 · primary_doc.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,745 F1 · shares: Represents shares withheld for taxes from vesting of time-based restricted stock units granted on 06/26/2017. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 14:52 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 3,500 | $39.95 | $139,825.00 |
DisclosureSEC source: 0001606498-19-000050 · wf-form4_155957351651954.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,556 Read SEC document |
| May 08, 2019 Filed May 10, 2019 13:56 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 122,069 | $43.59 Strike: $43.59 | $5,320,987.71 |
DisclosureSEC source: 0001606498-19-000042 · wf-form4_155749658928068.xml · derivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,069 Underlying: Common Stock · 122,069 shares Expires 2029-05-08 F1 · shares: Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. F2 · derivative.exercise_date: The award will vest 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 19:03 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 3,500 | $43.35 | $151,725.00 |
DisclosureSEC source: 0001606498-18-000077 · wf-form4_154351818336242.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,056 Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 20:06 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 3,488 | $58.19 | $202,966.72 |
DisclosureSEC source: 0001606498-18-000061 · wf-form4_153021637956863.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,556 Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:31 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 180,716 | $0.00 Strike: $52.10 | $0.00 |
DisclosureSEC source: 0001606498-18-000048 · wf-form4_152546585990733.xml · derivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,716 Underlying: Common Stock · 180,716 shares Expires 2028-05-03 F1 · derivative.exercise_date: The stock option awards vest 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021, subject to earlier vesting in the event of death, disability or certain other events. 155,150 of the stock options are an annual award, and 25,566 of them are a one-time award related to the completion of the sale of the S&IP Business to Owens & Minor, Inc. on April 30, 2018. Read SEC document |
| May 03, 2018 Filed May 8, 2019 19:42 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 25,566 | $52.10 Strike: $52.10 | $1,331,988.60 |
DisclosureSEC source: 0001606498-19-000038 · wf-form4a_155734453777701.xml · derivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,999 Underlying: Common Stock · 25,566 shares Expires 2028-05-03 F3 · shares: As reported on the original Form 4 filed on 5/4/2018, the reporting person was issued 25,566 stock options as a one-time award for the sale of the SI&P business. F2 · derivative.exercise_date: The awards vested, or will, vest 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 03, 2018 Filed May 8, 2019 19:42 UTC Amendment | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 103,433 | $52.10 Strike: $52.10 | $5,388,859.30 |
DisclosureSEC source: 0001606498-19-000038 · wf-form4a_155734453777701.xml · derivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,433 Underlying: Common Stock · 103,433 shares Expires 2028-05-03 F1 · shares: This Form 4/A is being filed to correct the original Form 4 filed on 5/4/2018. That Form 4 reported the number of stock options issued to the reporting person as 155,150, but, as described in detail in our Amended Proxy Statement dated 4/17/2019, the actual number of stock options that should have been issued is 103,433. The Company has rescinded the excess 51,717 stock options incorrectly issued to the reporting person. F2 · derivative.exercise_date: The awards vested, or will, vest 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:02 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 149,053 | $0.00 Strike: $39.93 | $0.00 |
DisclosureSEC source: 0001606498-17-000044 · wf-form4_149859736177614.xml · derivative · entry 2 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,053 Underlying: Common Stock · 149,053 shares Expires 2027-06-26 F2 · derivative.exercise_date: The awards vest 30% on June 26, 2018, 30% on June 26, 2019, and 40% on June 26, 2020, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:02 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 25,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-17-000044 · wf-form4_149859736177614.xml · nonDerivative · entry 1 Woody Joseph Fralin · CIK 0001709989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,044 F1 · shares: Represents time-vested restricted stock units that vest 33.3% on June 26, 2018, 33.3% on June 26, 2019 and 33.4% on June 26, 2020, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.